Skip to main content

Table 2 Summary of primary HCC treated SBRT with or without transarterial chemoembolization

From: Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis

No Age Sex Tumor site Tumor volume (cc) SBRT dose (Gy) Response Status (months)
1 59 F Right lobe 25.0 30 PR DOI(2.0)
2 63 F Right lobe 5.4 36 CR NED(18.5)
3 52 F Right lobe 28.6 30 PR A&D(16.0)
4 57 F Right lobe 23.5 36 CR NED(14.5)
5 78 M Right lobe 26.5 36 CR NED(14.0)
6 56 F Right lobe 31.9 36 PR A&D(13.0)
7 75 M Right lobe 25.2/27.5 39/36 SD/CR A&D(13.0)
8 60 M Right lobe 36.5 36 PR A&D(12.5)
9 56 M Left lobe 15.4 36 CR NED(12.5)
10 70 F Right lobe 16.9 36 SD A&D(12.0)
11 44 M Right lobe 16.6 30 PR NED(12.0)
12 48 M Right lobe 35.1 30 SD A&D(12.0)
13 77 M Right lobe 33.3 33 PR DOI(11.5)
14 60 M Right lobe 6.9 36 CR A&D(11.0)
15 55 M Right lobe 12.0 36 PR A&D(10.0)
16 62 F Right lobe 31.3 30 PR A&D(9.0)
17 56 F Right lobe 17.6 33 PR A&D(9.0)
18 62 M Right lobe 21.6 30 SD A&D(8.5)
19 75 M Right lobe 13.6 33 PR A&D(8.5)
20 48 M Right lobe 12.0 36 PR A&D(8.0)
21 62 M Right lobe 57.3 30 PR A&D(7.5)
22 67 M Right lobe 3.6 30 PR A&D(6.0)
23 57 M Portal vein 47.7 36 PR DOM(2.0)
24 60 M Portal vein 16.2 36 PR NED(15.0)
25 46 F Portal vein 28.3 36 SD DOI(3.0)
26 71 F Portal vein 3.9 30 SD A&D(13.0)
27 44 M Portal vein 38.9 30 SD DOI(12.0)
28 63 F Portal vein 34.7 30 SD A&D(8.5)
29 55 M Portal vein 37.0 30 CR NED(8.0)
30 48 M Portal vein 23.7 30 SD DOI(7.0)
31 57 F Portal vein 32.8 30 PR A&D(6.0)
  1. No, number, SBRT, stereotactic body radiation therapy, CR, complete response, PR, partial response, SD, stable disease, PD, progression disease, DOI, death of intercurrent disease, NED, no evidence of disease A&D, alive of disease, DOM, death of metastatic disease.